Croquet Launches Edge Collaboration Platform and Global Developer Infrastructure for Creating Real-Time, Multi-User Web and Mobile Applications
24.8.2021 14:00:00 EEST | Business Wire | Press release
The world’s perception of what real-time collaboration can actually look like is about to change. Croquet Corporation, the technology leader in Edge Collaboration (a new, rapidly-growing sector of Edge Computing) has launched the Croquet Collaboration Platform™ allowing developers worldwide to create multi-user apps with real-time capabilities never before possible.
While Croquet’s exclusive mission is delivering developer tools and infrastructure – including the Croquet Library, APIs and highly useful frameworks – the company has launched a free reference app called PiiX (Photo Instantaneous Interactive Experience) to showcase the technology. PiiX allows anyone, from consumers to sophisticated developers, to test-drive this revolutionary new collaboration technology right now, with no registration required.
Scan a QR code and watch as PiiX, a real-time, collaborative annotation app jumps instantly onto your phone or tablet. Invite others and as you annotate or manipulate the image, the results appear simultaneously in real-time on all participant screens. All users have simultaneous control. Users often describe the experience as “magical”. But it’s the global infrastructure underneath, with frameworks on top, that make everything possible. Click here to try PiiX.
“We believe that all future applications should be collaborative – including apps for productivity, social collaboration, telemedicine, sports, interactive marketing, AR/VR, SaaS, gaming, you name it,” says David A. Smith, Founder & CTO of Croquet. “With this launch, Croquet is delivering all of the tools and infrastructure developers need to easily build mind-blowing, real-time, fully synchronous collaborative apps that make today’s multi-user apps look like anachronisms. We expect that developers will find amazing ways to use this technology that we haven’t even imagined yet.”
Croquet was funded in early 2020 to pursue development and private beta testing of the infrastructure, libraries, tools and reference app launched today. Use cases for the technology are vast and varied across startups, the enterprise, commercial applications, social collaboration, media, marketing, interactive advertising and social games. See more use case detail on the Croquet website.
A Peek Under the Hood
Croquet’s first-of-its-kind Edge Collaboration infrastructure is deployed globally today on every continent (except Antarctica). It provides a super-fast reflector-based network (with latency as low as 10-15ms, depending on location), as well as a unique edge collaboration protocol and synchronization service that enable real-time collaboration at the edge of the network where performance is best. Servers have long stood between users and real-time collaboration. With Edge Collaboration, nothing runs on servers so developers are free to easily create apps for instantaneous shared experiences.
All the “smarts” of the application are on the client side. Each user is operating a shared virtual machine, with everyone’s device guaranteed to run the exact same program at exactly the same time, in exactly the same way. These client-side, bit-identical virtual machines use a replicated computation model that enables ultra-low latency, low bandwidth synchronization and instantaneous interactions.
Applications generate events which are sent to an Edge Reflector, the architectural center of the Croquet infrastructure, which then redistributes it to each session participant’s replicated virtual machine, providing precise synchronization with exceedingly low latency. Reflectors are small pieces of software that sit on the Edge and are spun up or down as needed anywhere in the world to support high performance sessions. Croquet Infrastructure is highly scalable with reflectors running across the globe, all designed to work with existing online and mobile networks, including 5G. Developers can sign up here to receive a free key allowing them to start using Croquet.
“Croquet is the best thing I’ve seen in computing over the last 15 years,” says Alan Kay, an advisor to Croquet since its inception, and Turing Award Winner long considered Father of the Personal Computer. “It solves massive problems associated with building real-time collaborative applications in extremely elegant ways. The Internet has been needing this for many years.”
Other key facts about the Croquet Library, API and frameworks include:
- No back-end code; simple front-end, client-side only. Easy for even novice programmers
- Fast and simple to implement. Changes the entire multi-user app development dynamic so developers can build and deploy multi-user apps in days, not months
- Application state is automatically shared so new users can join a live session instantly
- Abstracts the developer from powerful underlying infrastructure; it just works
- Multiple frameworks available for critical tasks
- Works globally with extremely low latency
- Privacy-focused; every message is encrypted end-to-end. The servers only see encrypted data; so even leaks would do no harm to privacy
- No timing issues or out-of-order events. Croquet uses “replicated computation” to eliminate message “collisions”
- Edge reflectors exist as software and have no application state; they are extraordinarily scalable globally and can function as a self-proliferating network
- View this technical FAQ on the Croquet website
Development of the company’s current technology was led by Smith and co-founders Vanessa Freudenberg, Aran Lunzer, Yoshiki Ohshima and Brian Upton – a team of architects and engineers in Los Angeles, CA.
“This is an amazing team that has built something remarkable,” says John Payne, CEO of Croquet. “The Croquet Platform and Infrastructure will enable a whole new breed of applications that couldn’t exist before while supporting the addition of collaboration features to existing applications around the world in a highly scalable way.”
The market for collaboration technology as a whole is massive. COVID has accelerated demand by 10 years, but so far the technology has lagged. Croquet changes the conversation, enabling a huge leap forward in developing Instantaneous Shared Experiences.
About Croquet
Croquet Corporation – the technology leader in Edge Collaboration, a new, rapidly-growing sector of Edge Computing – operates a global Edge Collaboration Platform and Collaboration Infrastructure that enables developers to quickly and easily create a vast range of multi-user collaboration apps for web and mobile, at virtually limitless scale. Croquet has its spiritual roots in work begun in the 1990’s by Founder & CTO David A. Smith, Alan Kay, David P. Reed and Andreas Raab in the Croquet Project, an open source 2D/3D environment for collaborative work written in Smalltalk. Croquet was formed in 2019 and funded by SIP Global Partners and a group of experienced technology and financial industry veterans. Visit www.croquet.io.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210824005340/en/
Contact information
Media/Analyst Contact: Daniel Kehrer: daniel.kehrer@croquet.io
Partnerships Contact: Stu Kozlowski: stu@croquet.io
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
